https://wnbfactory.com/images/totoslot138/ https://wnbfactory.com/images/slot303/ https://wnbfactory.com/images/totoslot4d/
Drug Innovation – Page 7 – Pacific Research Institute

Drug Innovation

Commentary

Pay No Attention To Biden’s Biotech Bluster

Speaking in Boston earlier this month, President Biden insisted that the United States can “end cancer as we know it and even cure cancers once and for all.”   His “Cancer Moonshot” aims to do just that. Among its many lofty goals, it seeks to halve cancer deaths in the next 25 years. ...
Commentary

The FDA Is Blocking Game-Changing New Drugs For Kidney Disease

Imagine you’ve been diagnosed with chronic kidney disease, told by your physician that if it can’t be managed, you may eventually need a transplant or long-term dialysis. This scary situation is one faced by hundreds of thousands of Americans every year. Chronic kidney disease (CKD) is an illness that affects an ...
Commentary

Drug Importation Doesn’t Save Money — It Costs Lives

Proponents of prescription-drug importation notched a victory last week. The Senate Health, Education, Labor, and Pensions Committee green-lit a bill that would enable individuals to import medicines from Canada in the name of lowering out-of-pocket costs. It’s not something Americans should welcome or support. Drugs imported from outside the United States will ...
Commentary

Promote Regulatory Certainty By Reauthorizing UFA

The House passed bipartisan legislation last week that could help reduce costs and ensure continued innovation for the future. While this legislation might not be covered as extensively as other issues, it nonetheless represents meaningful progress. This week, the Senate HELP Committee passed the Senate version, the Food and Drug ...
Commentary

Democrats Abandon US Patients to Rescue Drug-Pricing Reform

Just a few days ago, it appeared that Democrats had given up on including prescription drug pricing reforms in their massive spending bill. But not anymore. In an eleventh-hour turn of events, congressional Democrats this week resurrected their long-standing desire to levy government price controls on prescription drugs. If lawmakers successfully deploy their latest ...
Commentary

Democrats $3.5 Trillion Budget Leaves the Health Care Sector as Broken as Ever

One of the most striking aspects of the $3.5 trillion budget resolution proposed last week by Senate Democrats is how little it does to improve America’s ailing healthcare system. The plan funnels massive sums of money into everything from Medicare and Medicaid to Obamacare’s premium tax credits. But it utterly fails to ...
Commentary

Biden’s Intellectual Property Waiver Puts Political Symbolism Before Saving Lives

President Biden recently backed a World Trade Organization proposal to waive intellectual property protections on COVID-19 vaccines and therapies — a move the Trump administration rejected just a few months ago. The White House’s decision is a catastrophe. The waiver will do nothing to increase access to vaccines. It will, however, undermine the system ...
Commentary

Trump wrongly attacks life-saving drug companies on coronavirus vaccines and more

President Trump announced Friday that he will proceed with his plans to peg the prices of certain drugs prescribed largely at doctors’ offices under Medicare Part B to the lower prices that other developed nations pay for those drugs. That may sound good at first glance, but in reality, the move will slow ...
Drug Importation

NEW BRIEF: Counterfeit Drugs Harm Patients, Economy, Innovation

A new brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute shows that counterfeit drugs put patients in harm’s way, hinder drug innovation, and lead to job losses. Proposals like drug importation or price controls, if implemented, would exacerbate the problem and ...
Commentary

Price Controls Are Disastrous For Rents And Will Be For Drugs

President Trump and senior advisor Jared Kushner claim that the most favored nation executive order signed by the President over the weekend is necessary for drug pricing because “the U.S. shouldn’t pay more than other European countries for the same treatments.” This policy will make things worse, not better. If the president ...
Commentary

Pay No Attention To Biden’s Biotech Bluster

Speaking in Boston earlier this month, President Biden insisted that the United States can “end cancer as we know it and even cure cancers once and for all.”   His “Cancer Moonshot” aims to do just that. Among its many lofty goals, it seeks to halve cancer deaths in the next 25 years. ...
Commentary

The FDA Is Blocking Game-Changing New Drugs For Kidney Disease

Imagine you’ve been diagnosed with chronic kidney disease, told by your physician that if it can’t be managed, you may eventually need a transplant or long-term dialysis. This scary situation is one faced by hundreds of thousands of Americans every year. Chronic kidney disease (CKD) is an illness that affects an ...
Commentary

Drug Importation Doesn’t Save Money — It Costs Lives

Proponents of prescription-drug importation notched a victory last week. The Senate Health, Education, Labor, and Pensions Committee green-lit a bill that would enable individuals to import medicines from Canada in the name of lowering out-of-pocket costs. It’s not something Americans should welcome or support. Drugs imported from outside the United States will ...
Commentary

Promote Regulatory Certainty By Reauthorizing UFA

The House passed bipartisan legislation last week that could help reduce costs and ensure continued innovation for the future. While this legislation might not be covered as extensively as other issues, it nonetheless represents meaningful progress. This week, the Senate HELP Committee passed the Senate version, the Food and Drug ...
Commentary

Democrats Abandon US Patients to Rescue Drug-Pricing Reform

Just a few days ago, it appeared that Democrats had given up on including prescription drug pricing reforms in their massive spending bill. But not anymore. In an eleventh-hour turn of events, congressional Democrats this week resurrected their long-standing desire to levy government price controls on prescription drugs. If lawmakers successfully deploy their latest ...
Commentary

Democrats $3.5 Trillion Budget Leaves the Health Care Sector as Broken as Ever

One of the most striking aspects of the $3.5 trillion budget resolution proposed last week by Senate Democrats is how little it does to improve America’s ailing healthcare system. The plan funnels massive sums of money into everything from Medicare and Medicaid to Obamacare’s premium tax credits. But it utterly fails to ...
Commentary

Biden’s Intellectual Property Waiver Puts Political Symbolism Before Saving Lives

President Biden recently backed a World Trade Organization proposal to waive intellectual property protections on COVID-19 vaccines and therapies — a move the Trump administration rejected just a few months ago. The White House’s decision is a catastrophe. The waiver will do nothing to increase access to vaccines. It will, however, undermine the system ...
Commentary

Trump wrongly attacks life-saving drug companies on coronavirus vaccines and more

President Trump announced Friday that he will proceed with his plans to peg the prices of certain drugs prescribed largely at doctors’ offices under Medicare Part B to the lower prices that other developed nations pay for those drugs. That may sound good at first glance, but in reality, the move will slow ...
Drug Importation

NEW BRIEF: Counterfeit Drugs Harm Patients, Economy, Innovation

A new brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute shows that counterfeit drugs put patients in harm’s way, hinder drug innovation, and lead to job losses. Proposals like drug importation or price controls, if implemented, would exacerbate the problem and ...
Commentary

Price Controls Are Disastrous For Rents And Will Be For Drugs

President Trump and senior advisor Jared Kushner claim that the most favored nation executive order signed by the President over the weekend is necessary for drug pricing because “the U.S. shouldn’t pay more than other European countries for the same treatments.” This policy will make things worse, not better. If the president ...
Scroll to Top